Zoetis Inc.
ZOE.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$29.22B
Close$
Share Statistics
| Market cap | $29.22 Billion |
|---|---|
| Enterprise Value | $28.07 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 83.10% |
|---|---|
| Return on Assets | 17.35% |
| Return on Invested Capital | 27.04% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.95 |
| Enterprise Value to EBIT | 7.97 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zoetis Inc
9,200 employees
CEO: Kristin Peck Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines...